[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369318-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369318-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-novel-prognostic-scoring-model-based-on-cuproptosis-identifies-commd1-as-a-novel-therapy-target-for-liver-hepatocellular-carcinoma","A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma","","Primary liver cancer represents a major global health burden, with cuproptosis—a copper-dependent cell death mechanism—implicated in cancer pathogenesis, progression, and prognosis, including hepatocellular carcinoma (HCC). This study builds an HCC prognostic model using cuproptosis-related genes, integrating clinical features and gene expression profiles from TCGA and GEO. TCGA patients were split into training and testing sets, and Lasso Cox regression generated a predictive framework. The analysis highlights COMMD1, supported by cellular functional validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-novel-prognostic-scoring-model-based-on-cuproptosis-identifies-commd1-as-a-novel-therapy-target-for-liver-hepatocellular-carcinoma/369318/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-novel-prognostic-scoring-model-based-on-cuproptosis-identifies-commd1-as-a-novel-therapy-target-for-liver-hepatocellular-carcinoma/369318.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study?","Question",{"text":63,"@type":64},"To develop a prognostic model for hepatocellular carcinoma based on cuproptosis-related genes using TCGA and GEO data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the prognostic model constructed?",{"text":68,"@type":64},"TCGA patients were randomly divided into training and testing sets, and Lasso Cox regression was applied to build the predictive model from cuproptosis-related genes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which gene was identified as a key prognostic marker, and what evidence supports it?",{"text":72,"@type":64},"COMMD1 was identified as a potential prognostic marker, and cellular functional experiments validated its role in HCC progression and relevance as a therapy target.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369318,1790438814,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","ONCOLOGY RESEARCH 2025 33(3): 617-630 ARTICLE  \nA novel prognostic scoring model based on cuproptosis identiﬁes COMMD1 as a novel therapy target for liver hepatocellular carcinoma  \nKE TIAN 1; ZHIPENG LI2; XIANGYU ZHAI2,3; HUAXIN ZHOU2; HUI YAO 1,*  \n1 General Surgery Department 2, The No. 2 People’s Hospital of Lanzhou, Lanzhou, 730030, China  \n2 The Hepatobiliary Surgery Department, The Second Hospital of Shandong University, Jinan, 250000, China  \n3 Organ Transplant Department, Qilu Hospital of Shandong University, Jinan, 250000, China  \nKey words: Cuproptosis, Hepatocellular carcinoma (HCC), Copper homeostasis, Prognostic model, Immunocytes  \nAbstract: Background: Primary liver cancer poses a signiﬁcant global health burden, with projections indicating a surpassing of one million cases by 2025 . Cuproptosis, a copper-dependent mechanism of cell death, plays a crucial role in the pathogenesis, progression, and prognosis of various cancers, including hepatocellular carcinoma (HCC) .  \nPurpose: This study aimed to develop a prognostic model for HCC based on cuproptosis-related genes, utilizing clinical data and gene expression proﬁles from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Materials and Methods: Clinical features and gene expression data of HCC patients were collected from publicly available databases. Patients from TCGA were randomly divided into training and testing sets, and Lasso Cox regression was applied to develop a predictive model using cuproptosis-related genes. Results: The analysis identiﬁed Copper Metabolism Domain Containing 1 (COMMD1) as a potential prognostic marker for HCC, with deletion of this gene impacting disease progression. Cellular functional experiments validated the role of COMMD1 in HCC. Conclusions: COMMD1 emerges as a promising candidate for HCC treatment, with implications for prognosis  \nprediction and therapeutic targeting.  \nAbbreviations  \nCOMMD1 Copper Metabolism Domain Containing 1  \nWB Western blot  \nTTM Tetrathiomolybdate  \nCCK8 Cell Counting Kit-8  \nFOV Fields of View  \nHCC Hepatocellular carcinoma  \nGEO Gene Expression Omnibus  \nTCGA The Cancer Genome Atlas  \nDLAT Dihydrolipoamide S-acetyltransferase GDC Genomic Data Commons  \nGSVA Gene Set Variation Analysis TTM Tetrathiomolybdate  \nTCA Tricarboxylic acid cycle  \nROS Reactive Oxygen Species  \n*Address correspondence to: Hui Yao, [yaohui0823@126.com](yaohui0823@126.com)[ ](yaohui0823@126.com)[Received: 17 January 2024](Received: 17 January 2024); [Accepted: 16 May 2024](Accepted: 16 May 2024);  \nPublished: 28 February 2025  \nDoi: 10.32604/or.2024.049772  \nIntroduction  \nHCC represents 75%–85% of primary liver cancer cases and is the ﬁfth most common cancer globally, ranking third in cancer-related mortality. Annually, approximately 5 million new cases are reported [1] . In addition to HCC, primary liver cancer also consists of intrahepatic cholangiocarcinoma (10%–15%) and other less common forms. Thanks to advancements in vaccines and treatments, the incidence of liver cancer caused by Hepatitis B virus (HBV) and Hepatitis C virus (HCV) is decreasing [2] . There has been a rise in liver cancer linked to alcohol, tobacco, and prolonged aﬂatoxin exposure [3,4] . Limited research exists on breast cancer metastasizing to the liver within the scientiﬁc community. Patients experiencing liver metastases face a grim prognosis, enduring a median survival period of merely 14–16 months irrespective of treatment modalities [5] . The effectiveness of ICIs as primary or secondary treatments for HCC did not result in a notable enhancement inpatient outcomes [6,7] . Nevertheless, given the diversity of  \n[www.techscience.com/journal/or](www.techscience.com/journal/or)  \nCopyright © 2025 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the or","cbCaidK5XeqyjsCt","https://ap.wps.com/l/cbCaidK5XeqyjsCt","pdf",29713958,14,"English","# Introduction\n## Cuproptosis and its relevance to liver cancer\n# Materials and Methods\n## Data sources and cohort splitting\n## Model construction using Lasso Cox regression\n# Results\n## Identification of COMMD1 as a prognostic marker\n## Functional validation in HCC cells\n# Conclusion\n## COMMD1 as a therapeutic target","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To develop a prognostic model for hepatocellular carcinoma based on cuproptosis-related genes using TCGA and GEO data.\"},{\"question\":\"How was the prognostic model constructed?\",\"answer\":\"TCGA patients were randomly divided into training and testing sets, and Lasso Cox regression was applied to build the predictive model from cuproptosis-related genes.\"},{\"question\":\"Which gene was identified as a key prognostic marker, and what evidence supports it?\",\"answer\":\"COMMD1 was identified as a potential prognostic marker, and cellular functional experiments validated its role in HCC progression and relevance as a therapy target.\"}]","A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma | PDF",1790181982,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d7d349caf7172268c2c43e6a8ebf1e0.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39ffb72bd0c33ca1c4a5b5b79d38c0cf.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1617a1dd350bfddef7ea3c89632d52ba.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c00e857f2cf5e3108a85912f0d94f41b.webp",980,1385]